Sign up for the QMED & MD+DI Daily newsletter.
Omar Ford
March 29, 2018
11 Slides
First Quarter Filled with Deals, Controversy and ApprovalsCEOs facing SEC charges, bold acquisitions, tiny insulin devices, and “unique” procedures were some of the events that made the first quarter of 2018 memorable.
10 Events that Rattled Medtech in 1Q18
About the Author(s)
You May Also Like